Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 12/20 | 0.70 |
| ▸ | NMBR | P28336 | 1/20 | 0.61 |
| ▸ | GRPR | P30550 | 1/20 | 0.61 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.61 |
| ▸ | GLP1R | P43220 | 4/20 | 0.59 |
| ▸ | GIPR | P48546 | 4/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29150398 | 0.88 | CCKBR (0.62) | CCKBR | |
| SCHEMBL30305898 | 0.87 | CCKBR (0.83) | CCKBR | |
| SCHEMBL30533211 | 0.86 | CCKBR (0.83) | CCKBR | |
| SCHEMBL23928719 | 0.86 | CCKBR (0.67) | CCKBR | |
| SCHEMBL29349773 | 0.86 | CCKBR (0.67) | CCKBR | |
| SCHEMBL29362913 | 0.86 | CCKBR (0.67) | CCKBR | |
| SCHEMBL31182464 | 0.85 | GLP1R (0.62) | CXCR4GLP1RGIPR | |
| SCHEMBL29414561 | 0.85 | CCKBR (0.80) | CCKBR | |
| SCHEMBL31015845 | 0.85 | CCKBR (0.82) | CCKBR | |
| SCHEMBL30951444 | 0.85 | CCKBR (0.82) | CCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12605447-B2 | Stable formulations for radionuclide complexes | ITM SOLUCIN GMBH (DE) | 2026-04-21 | — | — | US | disclosed |
| US-20250170243-A1 | STABLE FORMULATIONS FOR RADIONUCLIDE COMPLEXES | LSI FINANCING LLC, AS ADMINISTRATIVE AGENT | 2025-05-29 | — | — | US | disclosed |
| US-20240374732-A1 | STABLE FORMULATIONS FOR RADIONUCLIDE COMPLEXES | LSI FINANCING LLC, AS ADMINISTRATIVE AGENT | 2024-11-14 | — | — | US | disclosed |
| US-20230414796-A1 | COMBINATION OF PARA-AMINOHIPPURIC ACID (PAH) AND RADIOLABELED COMPLEXES FOR TREATING CANCER | ITM Isotope Technologies Munich SE (DE) | 2023-12-28 | — | — | US | disclosed |
| EP-4065176-B1 | COMBINATION OF PARA-AMINOHIPPURIC ACID (PAH) AND RADIOLABELED COMPLEXES FOR TREATING CANCER | ITM ISOTOPE TECH MUNICH SE (DE) | 2023-10-11 | — | — | EP | disclosed |
| EP-4218749-A1 | PARA-AMINOHIPPURIC ACID (PAH) AS A RENAL PROTECTIVE SUBSTANCE | ITM Isotope Technologies Munich SE (DE) | 2023-08-02 | — | — | EP | disclosed |
| EP-3965751-B1 | PARA-AMINOHIPPURIC ACID (PAH) AS A RENAL PROTECTIVE SUBSTANCE | ITM ISOTOPE TECH MUNICH SE (DE) | 2022-12-28 | — | — | EP | disclosed |
| US-20220304964-A1 | PARA-AMINOHIPPURIC ACID (PAH) AS A RENAL PROTECTIVE SUBSTANCE | LSI FINANCING LLC, AS ADMINISTRATIVE AGENT | 2022-09-29 | — | — | US | disclosed |
| CN-114126654-A | Para-aminohippuric acid (PAH) as a kidney protective substance | 同位素技术慕尼黑有限公司 | 2022-03-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12605447-B2 | Stable formulations for radionuclide complexes | EPOR, CD47, PRCP | CCKBR 107/4885NMBR 895/4885GRPR 30/4885 |
| US-20250170243-A1 | STABLE FORMULATIONS FOR RADIONUCLIDE COMPLEXES | SLC40A1, SLC7A11, GYPA | CCKBR 1119/4885NMBR 1168/4885GRPR 316/4885 |
| US-20220304964-A1 | PARA-AMINOHIPPURIC ACID (PAH) AS A RENAL PROTECTIVE SUBSTANCE | PAH, SLCO1B1, SLCO2B1 | CCKBR 1100/4885NMBR 2030/4885GRPR 383/4885 |
| US-20240374732-A1 | STABLE FORMULATIONS FOR RADIONUCLIDE COMPLEXES | SLC40A1, SLC7A11, GYPA | CCKBR 1085/4885NMBR 1129/4885GRPR 324/4885 |
| US-20230414796-A1 | COMBINATION OF PARA-AMINOHIPPURIC ACID (PAH) AND RADIOLABELED COMPLEXES FOR TREATING CANCER | PAH, VHL, SLC10A6 | CCKBR 389/4885NMBR 899/4885GRPR 131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.